Hypothesis

In aged CD8+ T cells, progressive loss of TET2-mediated 5hmC at specific enhancers of exhaustion and senescence genes leads to increased DNA methylation, transcriptional silencing of progenitor programs, and an accelerated epigenetic aging signature. Supplementation with vitamin C, as a TET cofactor, restores 5hmC levels at these loci, rejuvenates the epigenetic clock, and improves functional resilience.

Rationale

• TET2 oxidation of 5mC to 5hmC is required for maintaining accessible chromatin at enhancers of Tcf7, Sell, and Il7r in progenitor exhausted T cells (TEXprog) TET2 promotes terminal exhaustion.
• Loss of TET2 activity results in focal 5mC gains at regulatory regions, as shown for Zbtb7b in thymocytes WGBS confirms focal 5mC gains.
• Vitamin C enhances TET enzymatic activity and increases global 5hmC in non-immune cells, indicating that cofactor limitation can modulate TET output vitamin C induces dose-dependent genomic 5hmC increases.
• Aging T cells exhibit "meta-epigenetic shifts" characterized by altered DNA methylation patterns that correlate with functional decline meta-epigenetic shifts in aging T-cells.
• Mesenchymal stem cell–mediated thymic rejuvenation demonstrates that DNA methylation reprogramming can reverse age-related phenotypes mesenchymal stem cells reverse thymus aging.

Combining these observations, we propose that age-related decline in TET2 activity—or its cofactor availability—leads to locus‑specific 5hmC erosion, which in turn drives epigenetic aging of T cells.

Predictions

1. 5hmC loss at exhaustion-associated enhancers will be detectable in sorted CD8+ T cells from old (≥20 mo) mice compared with young (8 wk) mice, using oxidative bisulfite sequencing (oxBS‑seq) or APOBEC‑coupled 5hmC sequencing.
2. Increased DNA methylation (5mC) will inversely correlate with 5hmC loss at the same sites, measurable by parallel WGBS.
3. Epigenetic aging clocks (e.g., Horvath’s mouse clock or a T‑cell‑specific clock) will show advanced epigenetic age in old T cells, and this acceleration will correlate with the magnitude of 5hmC loss at target enhancers.
4. Vitamin C supplementation (in vivo via drinking water or ex vivo culture) will restore 5hmC levels at the identified enhancers, reduce local 5mC, and reset the epigenetic age score toward youthful values.
5. Functional rescue will manifest as increased proportion of TEXprog (TCF1+ GZMB−) cells, enhanced proliferative capacity upon antigen re‑challenge, and improved tumor control in adoptive transfer models.

Experimental Design

• Mouse cohorts: Young and aged C57BL/6 mice; aged mice receive vitamin C (1 g/L drinking water) for 8 weeks; controls receive regular water.
• Cell sorting: Purify CD8+ T cells, further subdivide into naive, TEXprog, and terminally exhausted (TEXterm) based on CD44, PD‑1, TCF1, and GZMB expression.
• 5hmC/5mC mapping: Perform oxBS‑seq and TAB‑seq on each subset to quantify 5hmC and 5mC at enhancers of Tcf7, Sell, Il7r, Pdcd1, and Tox.
• Epigenetic age calculation: Use published CpG sites from T‑cell‑specific clocks to compute epigenetic age from WGBS data.
• Functional assays: Measure proliferation (CFSE dilution), cytokine production (IFN‑γ, TNF‑α) after LCMV gp33 peptide restimulation, and assess tumor infiltration in a melanoma model using transferred T cells.
• Controls: Include Tet2‑heterozygous mice to gauge gene‑dosage effects, and DNMT3a/b inhibitors to dissect methylation dynamics.

Potential Outcomes and Interpretation

• If aged T cells show significant 5hmC depletion at the predicted enhancers, accompanied by elevated 5mC and advanced epigenetic age, and vitamin C treatment reverses these molecular and phenotypic markers, the hypothesis is supported.
• If vitamin C fails to restore 5hmC or epigenetic age despite increased global 5hmC, this would suggest that TET2 activity is not the limiting factor, pointing to alternative mechanisms (e.g., altered TET recruitment or increased TDG/BER activity).
• Absence of correlation between locus‑specific 5hmC changes and epigenetic clock readings would challenge the idea that these specific sites drive aging‑related methylation shifts.

This framework directly links TET‑mediated 5hmC dynamics to epigenetic aging in T cells and offers a clear, testable route toward nutritional or pharmacological rejuvenation of adaptive immunity.